Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Scales Down: Efficiency Program Includes Prioritizing R&D Pipeline

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer is targeting its research budget on projects most likely to succeed as part of an R&D reorganization. Rationalization program will help Pfizer reach goal of $4 bil. in annual savings by 2008.

You may also be interested in...



Wyeth Will Supplement Reduced Sales Force With Part-Time Reps

Wyeth will cut full-times sales force by 25%-30% but will add part-time reps, resulting in a net reduction of approximately 15%, the company says.

Wyeth Will Supplement Reduced Sales Force With Part-Time Reps

Wyeth will cut full-times sales force by 25%-30% but will add part-time reps, resulting in a net reduction of approximately 15%, the company says.

No Merger Needed: Pfizer Efficiency Program To Generate $4 Bil. In Savings

Pfizer is launching a productivity initiative to generate $4 bil. in annual cost savings by 2008, the company announced during its New York City analyst meeting April 5

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062597

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel